Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Daphnetin in Ovarian Epithelial Carcinoma: NCT07495397 Clinical Landscape Report 2026
28 September 2026
NCT07495397 clinical landscape for Ovarian Epithelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roflumilast in Psoriasis vulgaris: CTRI/2026/03/0106289 Clinical Landscape Report 2026
28 September 2026
CTRI/2026/03/0106289 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
D-215 in BRCA-mutated Fallopian Tube Carcinoma: NCT07532148 Clinical Landscape Report 2026
28 September 2026
NCT07532148 clinical landscape for BRCA-mutated Fallopian Tube Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
EB-NK-MF in Primary peritoneal carcinoma: NCT07480954 Clinical Landscape Report 2026
28 September 2026
NCT07480954 clinical landscape for Primary peritoneal carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GB-5627 in Platinum-Resistant Fallopian Tube Carcinoma: NCT07489287 Clinical Landscape Report 2026
28 September 2026
NCT07489287 clinical landscape for Platinum-Resistant Fallopian Tube Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Memantine hydrochloride in Alzheimer Disease: NCT07531940 Clinical Landscape Report 2026
28 September 2026
NCT07531940 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lecanemab in Alzheimer Disease: NCT07544953 Clinical Landscape Report 2026
28 September 2026
NCT07544953 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Neural Stem Cell-Derived Exosomes(Shanghai Angecon Biotechnology) in Alzheimer Disease: NCT07554872 Clinical Landscape Report 2026
28 September 2026
NCT07554872 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Adalimumab biosimilar(Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.) in Pediatric Crohn's Disease: NCT07564505 Clinical Landscape Report 2026
28 September 2026
NCT07564505 clinical landscape for Pediatric Crohn's Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ethinyl Estradiol/Norethindrone Acetate/Ferrous Fumarate in Diabetes Insipidus: NCT07568509 Clinical Landscape Report 2026
28 September 2026
NCT07568509 clinical landscape for Diabetes Insipidus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CRPA1A2 in Hepatocellular Carcinoma: NCT07583316 Clinical Landscape Report 2026
28 September 2026
NCT07583316 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Infliximab in Colitis, Ulcerative: NCT07576452 Clinical Landscape Report 2026
28 September 2026
NCT07576452 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.